COVID-19 vaccine: Bivalent

by | Mar 24, 2023 | Uncategorized

From 1 March 2023 – bivalent vaccine replaces the existing Pfizer booster

Anyone who is currently eligible to receive a first or second booster will now receive the Pfizer Bivalent vaccine.

From 1 April 2023 – eligibility expanded for additional boosters

From 1 April 2023, an additional booster dose will be made available to:

  • anyone aged 30 and over who has completed their primary course (2 doses) as long as it has been at least 6 months since their last COVID-19 booster or positive COVID-19 test.
  • anyone at increased risk of severe illness from COVID-19 who has completed their primary course (2 doses), as long as it’s been at least 6 months since their last COVID-19 booster or positive COVID-19 test.

Those in the high-risk groups include:

  • people aged 65 years and over 
  • Māori and Pacific people aged 50 years and over 
  • residents of aged care and disability care facilities 
  • severely immunocompromised people 
  • people aged 16 years and over who have a medical condition that increases the risk of severe breakthrough COVID-19 illness 
  • people aged 16 years and over who live with disability with significant or complex health needs or multiple comorbidities. 

Anyone aged 16 to 29 who are not at increased risk of severe illness from COVID-19, are not eligible for an additional dose. The two-dose primary course and first booster dose provides very good protection from the risk of serious illness, hospitalisation or death from COVID-19.    

From 1 April 2023, the additional booster dose can only be given to eligible people whose most recent COVID-19 vaccine or positive COVID-19 test was at least 6 months ago. It does not matter how many previous doses that person has had.

Bookings

Please ensure you carefully check that you are eligible to receive the additional dose before making your booking.